Intuitive Surgical
ISRGQ4 2023(ISRG Q3 FY2023)Estimated2% AI
AI Revenue %
2%
AI Fair Value
$1.6B
AI Revenue (Q)
$34.9M
Total Revenue (Q)
$1.7B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
Q3 FY2023 total revenue $1,743.7M (Instruments & Accessories $1,071.4M, Systems $379.4M, Services $292.9M). No AI revenue disclosure. The Q3 2023 10-Q is the first filing where ISRG updates its business description to include 'The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. Both systems use software, instruments, and accessories.' Still no AI-specific revenue or segment. Conservative 2% estimate.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenue $1,743.7M: Instruments and accessories $1,071.4M, Systems $379.4M, Services $292.9M
10-Q 2023-09-30, Note 5
The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. Both systems use software, instruments, and accessories.
10-Q 2023-09-30, Note 1
AI Products Identified (Ring 1)
da Vinci vision system image processingIon endoluminal vision probesurgical instrument tracking software
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Instruments & AccessoriesSystems hardware
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix